Browse the evidence

Current rates of WMT utilization among patients with obesity are low, increasing from 5.3% to 7.1%.

Efforts should be made to increase the utilization of WMT among patients with obesity.

Serum levels of brain-derived neurotrophic factor (BDNF) significantly increased in the TRF group.

Increased BDNF levels may indicate improved brain function related to eating behaviors in women undergoing TRF.

Cognitive restriction scores were higher in the TRF group compared to the control group.

Higher cognitive restriction scores in the TRF group suggest improved self-regulation in eating behaviors.

Gastrointestinal adverse effects were common, but the medication was otherwise well tolerated.

Clinicians should inform patients about potential gastrointestinal side effects while considering the overall tolerability of the treatment.

Treatment persistence was high, with 80% of patients completing 6 months of therapy.

High treatment persistence suggests that patients are likely to continue tirzepatide therapy.

Gastrointestinal adverse events were the most frequently reported but rarely led to treatment discontinuation.

Practitioners should monitor for gastrointestinal side effects but can expect them to be manageable.

Resting metabolic rate (RMR) decreased during the caloric restriction (CR) intervention compared to baseline.

Practitioners should note that caloric restriction can lead to a decrease in resting metabolic rate over time.

There was no evidence for long-term metabolic adaptation to weight loss in assessments of resting metabolic rate.

Practitioners should understand that weight loss may not lead to long-term changes in resting metabolic rate.

Gastrointestinal adverse effects were the most commonly reported side effects of retatrutide.

Clinicians should monitor for gastrointestinal side effects in patients treated with retatrutide.

The most common adverse events in the retatrutide groups were gastrointestinal and were mostly mild to moderate in severity.

Practitioners should monitor for gastrointestinal side effects in patients treated with retatrutide.

Low birth weight (< 5.5 lb) is associated with an increased risk of hypertension (age-adjusted odds ratio of 1.26) and diabetes mellitus (age-adjusted odds ratio of 1.75).

Practitioners should consider birth weight as a potential risk factor for hypertension and diabetes in adult patients.

High birth weight (≥ 10.0 lb) is associated with an increased risk of obesity (age-adjusted odds ratio of 2.08).

Practitioners should be aware that high birth weight may increase the risk of obesity in adult patients.

The study supports the hypothesis that early life exposures, indicated by birth weight, are associated with chronic diseases in adulthood.

Practitioners should consider the impact of early life factors, such as birth weight, on long-term health outcomes.

Women with birth weights > 10 lb have an age-adjusted odds ratio of 1.62 for being in the highest quintile of body mass index compared to those who weighed 7.1 to 8.5 lb at birth in NHS I.

Practitioners should be aware of the potential link between high birth weight and increased obesity risk in women.

Early life exposures affecting birth weight may be important in the development of hypertension and obesity in adults.

Practitioners should consider the impact of early life factors on long-term health outcomes in women.

Moderate weight gain is associated with lower odds of achieving a composite healthy aging outcome.

Weight management strategies may be crucial for promoting healthy aging.

Each 5-unit increment in BMI was associated with a 20% increased risk of early-onset CRC (RR 1.20).

Weight management strategies may be important for reducing early-onset CRC risk.

From 1999 to 2018, the estimated percentage of total energy from consumption of ultraprocessed foods increased from 61.4% to 67.0%.

Practitioners should be aware of the increasing trend in ultraprocessed food consumption among youths.

The percentage of total energy from consumption of unprocessed or minimally processed foods decreased from 28.8% to 23.5% from 1999 to 2018.

Practitioners should note the decline in consumption of unprocessed foods among youths.

There was a significantly larger increase in the estimated percentage of energy from ultraprocessed foods among non-Hispanic Black youths and Mexican American youths compared to non-Hispanic White youths.

Practitioners should consider demographic factors when addressing dietary habits among youths.

About 14% caloric restriction for 2 years in healthy humans improved thymopoiesis.

Caloric restriction may enhance immune function in healthy individuals.

Caloric restriction-induced transcriptional reprogramming in adipose tissue implicated pathways regulating mitochondrial bioenergetics, anti-inflammatory responses, and longevity.

Caloric restriction may promote metabolic health through specific molecular pathways.

Reduction of PLA2G7 may mediate the immunometabolic effects of caloric restriction and could potentially lower inflammation and extend health span.

Targeting PLA2G7 may be a strategy to reduce inflammation and improve health span.

Participation in leisure time physical activity is low but has remained relatively constant.

Encouraging increased leisure time physical activity could help address obesity.